Touraj Khosravi-Hafshejani
Board-Certified Dermatologist
Location: Coal Harbour
Language: English, Farsi
Specialization: Medical Dermatology & Clinical Trials
Dr. Touraj Khosravi-Hafshejani, MD, FRCPC, FAAD, is a board-certified dermatologist. He completed his Bachelor of Science in Pharmacology at the University of British Columbia, followed by his medical degree at UBC, graduating in 2019. He then pursued his dermatology residency at UBC, where he developed comprehensive expertise in medical and procedural dermatology.
Dr. Khosravi-Hafshejani further advanced his training through a specialized fellowship in Dermatology–Rheumatology at the University of Pennsylvania, equipping him with unique insight into complex inflammatory and autoimmune skin conditions. He is certified by both the Royal College of Physicians and Surgeons of Canada and the American Board of Dermatology, and is an active member of the Canadian Dermatology Association (CDA) and the American Academy of Dermatology (AAD).
Fluent in both English and Farsi, Dr. Khosravi-Hafshejani is committed to delivering patient-centered care to a diverse community. His clinical interests span a wide range of dermatologic conditions, including acne and acne scarring, eczema, psoriasis, rosacea, skin cancer, and pigmentation disorders. He also has experience in clinical trials, contributing to advancements in dermatologic treatments.
Dr. Khosravi-Hafshejani offers a comprehensive array of Dermatology treatments, these include skin checks, skin cancer treatments and excisions, cryotherapy, UV therapy, and treatments for conditions such as hidradenitis suppurativa, vitiligo, and excessive sweating. His procedural expertise includes lesion and cyst removal, cosmetic mole removal, and advanced surgical excisions. In addition, he provides injectable treatments such as Botox®, Dysport®, and platelet-rich plasma (PRP) for both medical and aesthetic indications.
Rejuvenation Dermatology’s Clinical Trials Department is a national, multi-site research network dedicated to advancing dermatologic care through ethically conducted, regulated clinical research. Integrated within routine clinical practice, the department partners with global pharmaceutical sponsors to evaluate novel therapies and offers early access to innovative treatment options. The team supports industry-sponsored and investigator-initiated trials across a broad range of indications, collaborating closely with sponsors, CROs, investigators, and ethics boards to deliver high-quality data while maintaining a strong commitment to patient safety.
Since its inception, the division has evolved from a single research-focused clinic into a coordinated, multi-province research network. Today, it operates with standardized infrastructure, centralized oversight, and experienced investigators across Canada.
